COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients

References

• Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34. doi:10.1016/j.cmi.2018.07.011.
   PubMed Web of Science ®Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13(2):236–301. doi:10.1128/CMR.13.2.236.
   PubMed Web of Science ®Google Scholar
• Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, et al. EpImpact of the use of digital devices on e of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), report 1. Indian J Ophthalmol. 2021;69(7):1670–1692. doi:10.4103/ijo.IJO_1565_21.
   PubMed Web of Science ®Google Scholar
• Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019;5(1):26. doi:10.3390/jof5010026.
   PubMedGoogle Scholar
• Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653. doi:10.1086/432579.
   PubMed Web of Science ®Google Scholar
• Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European confederation of medical mycology (ECMM) working group on zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17(12):1859–1867. doi:10.1111/j.1469-0691.2010.03456.x.
   PubMed Web of Science ®Google Scholar
• Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009;15(9):1395–1401. doi:10.3201/eid1509.090334.
   PubMed Web of Science ®Google Scholar
• Mortensen KL, Denning DW, Arendrup MC. The burden of fungal disease in Denmark. Mycoses. 2015;58 Suppl 5:15–21. doi:10.1111/myc.12383.
   PubMed Web of Science ®Google Scholar
• Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27(5):1138–1147. doi:10.1093/clinids/27.5.1138.
   PubMed Web of Science ®Google Scholar
• Webb BJ, Ferraro JP, Rea S, Kaufusi S, Goodman BE, Spalding J. Epidemiology and clinical features of invasive fungal infection in a US health care network. Open Forum Infect Dis. 2018;5(8):ofy187. doi:10.1093/ofid/ofy187.
   PubMed Web of Science ®Google Scholar
• Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021;9(3):523. doi:10.3390/microorganisms9030523.
   PubMed Web of Science ®Google Scholar
• Patel A, Kaur H, Xess I, Michael JS, Savio J, Rudramurthy S, et al. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020;26(7):e944.9–e944.15. doi:10.1016/j.cmi.2019.11.021.
   Web of Science ®Google Scholar
• Choksi T, Agrawal A, Date P, Rathod D, Gharat A, Ingole A, et al. Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India. JAMA Ophthalmol. 2022;140(1):66–72. doi:10.1001/jamaophthalmol.2021.5201.
   PubMed Web of Science ®Google Scholar
• Kuehn BM. Cluster of mucormycosis cases linked with delta surge. JAMA. 2022;327(6):518. doi:10.1001/jama.2022.0079.
   Web of Science ®Google Scholar
• Avatef Fazeli M, Rezaei L, Javadirad E, Iranfar K, Khosravi A, Amini Saman J, et al. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: an observational study. Mycoses. 2021;64(11):1366–1377. doi:10.1111/myc.13351.
   PubMed Web of Science ®Google Scholar
• Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146. doi:10.1016/j.dsx.2021.05.019.
   PubMed Web of Science ®Google Scholar
• Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021;69(2):244–252. doi:10.4103/ijo.IJO_3774_20.
   PubMed Web of Science ®Google Scholar
• Manesh A, Devasagayam E, Bhanuprasad K, Varghese L, Kurien R, Cherian LM, et al. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study. Clin Microbiol Infect. 2023;29:S1198–743. doi:10.1016/j.cmi.2023.06.017.
   Web of Science ®Google Scholar
• Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo SP, et al. CT imaging and differential diagnosis of COVID-19. Can Assoc Radiol J. 2020;71(2):195–200. doi:10.1177/0846537120913033.
   PubMed Web of Science ®Google Scholar
• Nair AG, Adulkar NG, D’Cunha L, Rao PR, Bradoo RA, Bapaye MM, et al. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Orbit. 2021;40(6):499–504. doi:10.1080/01676830.2021.1960382.
   PubMed Web of Science ®Google Scholar
• Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50(1):126–133. doi:10.1128/aac.50.1.126-133.2006.
   PubMed Web of Science ®Google Scholar
• van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006;42(7):e61–5. doi:10.1086/500212.
   PubMed Web of Science ®Google Scholar
• Dave TV, Gopinathan Nair A, Hegde R, Vithalani N, Desai S, Adulkar N, et al. Clinical presentations, management and outcomes of rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19: a multi-centric study. Ophthalmic Plast Reconstr Surg. 2021;37(5):488–495. doi:10.1097/IOP.0000000000002030.
   PubMed Web of Science ®Google Scholar
• Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021;69(6):1563–1568. doi:10.4103/ijo.IJO_310_21.
   PubMed Web of Science ®Google Scholar
• Pakdel F, Ahmadikia K, Salehi M, Tabari A, Jafari R, Mehrparvar G, et al. Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran. Mycoses. 2021;64(10):1238–1252. doi:10.1111/myc.13334.
   PubMed Web of Science ®Google Scholar
• Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids—an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021;20(3):418–425. doi:10.1007/s12663-021-01532-1.
   PubMed Web of Science ®Google Scholar
• Kurup LR, Singh H, Sharma SB, Janakiram TN. Outcome of total surgical debridement of COVID associated rhino-orbito-cerebral mucormycosis based on a new surgical staging system: a cohort study. Indian J Otolaryngol Head Neck Surg. 2024;76(1):298–308. doi: 10.1007/s12070-023-04151-z. Epub 2023 Aug 29. PMID: 38440527; PMCID: PMC10908694.
   PubMedGoogle Scholar
• Sharma A, Godha S, Verma J, Bhalot L, Gupta Y, Mundra RK. Novel grading system based on nasal endoscopy: our experience with 650 mucormycosis cases. Indian J Otolaryngol Head Neck Surg. 2024;76(2):1667–1673. doi: 10.1007/s12070-023-04380-2. Epub 2023 Dec 16. PMID: 38566709; PMCID: PMC10982223.
   PubMedGoogle Scholar
• Sharifi A, Akbari Z, Shafie’ei M, Nasiri N, Sharifi M, Shafiei M, et al. Retrobulbar injection of amphotericin B in patients with COVID-19 associated orbital mucormycosis: a systematic review. Ophthalmic Plast Reconstr Surg. 2022;38(5):425–432. doi:10.1097/IOP.0000000000002256.
   PubMed Web of Science ®Google Scholar
• Ashraf DC, Idowu OO, Hirabayashi KE, Kalin-Hajdu E, Grob SR, Winn BJ, et al. Outcomes of a modified treatment ladder algorithm using retrobulbar amphotericin B for invasive fungal rhino-orbital sinusitis. Am J Ophthalmol. 2022;237:299–309. doi:10.1016/j.ajo.2021.05.025.
   PubMed Web of Science ®Google Scholar
• Soni K, Das A, Sharma V, Goyal A, Choudhury B, Chugh A, et al. Surgical & medical management of ROCM (rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes – a tertiary care center experience. J Med Mycol. 2022;32(2):101238. doi:10.1016/j.mycmed.2021.101238.
   PubMed Web of Science ®Google Scholar
• Bayram N, Ozsaygılı C, Sav H, Tekin Y, Gundogan M, Pangal E, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. 2021;65(4):515–525. doi:10.1007/s10384-021-00845-5.
   PubMed Web of Science ®Google Scholar
• Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185(4):599–606. doi:10.1007/s11046-020-00462-9.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S16–22. doi:10.1093/cid/cir865.
   PubMed Web of Science ®Google Scholar
• Müller JA, Groß R, Conzelmann C, Krüger J, Merle U, Steinhart J, et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021;3(2):149–165. doi:10.1038/s42255-021-00347-1.
   PubMedGoogle Scholar
• Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, et al. A global analysis of mucormycosis in France: the RetroZygo study (2005–2007). Clin Infect Dis. 2012;54(Suppl 1):S35–43. doi:10.1093/cid/cir880.
   PubMed Web of Science ®Google Scholar
• Xu W, Peng J, Li D, Tsui CKM, Long Z, Wang Q, et al. Transcriptional profile of the human skin pathogenic fungus Mucor irregularis in response to low oxygen. Med Mycol. 2018;56(5):631–644. doi:10.1093/mmy/myx081.
   PubMed Web of Science ®Google Scholar